Annual Cash & Cash Equivalents
$22.43 M
-$10.93 M-32.76%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual cash & cash equivalents is $22.43 million, with the most recent change of -$10.93 million (-32.76%) on December 31, 2023.
- During the last 3 years, NRBO annual cash & cash equivalents has risen by +$12.35 million (+122.37%).
- NRBO annual cash & cash equivalents is now -32.76% below its all-time high of $33.36 million, reached on December 31, 2022.
Performance
NRBO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$21.67 M
-$6.26 M-22.43%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly cash and cash equivalents is $21.67 million, with the most recent change of -$6.26 million (-22.43%) on September 30, 2024.
- Over the past year, NRBO quarterly cash and cash equivalents has dropped by -$766.00 thousand (-3.41%).
- NRBO quarterly cash and cash equivalents is now -37.12% below its all-time high of $34.46 million, reached on March 31, 2018.
Performance
NRBO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NRBO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | -3.4% |
| 3 y3 years | +122.4% | +210.3% |
| 5 y5 years | +688.6% | +1068.1% |
NRBO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | +36.9% | -35.0% | +240.9% |
| 5 y | 5-year | -32.8% | +122.4% | -35.0% | +240.9% |
| alltime | all time | -32.8% | +6977.3% | -37.1% | +1230.2% |
NeuroBo Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.67 M(-22.4%) |
| Jun 2024 | - | $27.93 M(+74.7%) |
| Mar 2024 | - | $15.99 M(-28.7%) |
| Dec 2023 | $22.43 M(-32.8%) | $22.43 M(-13.2%) |
| Sep 2023 | - | $25.84 M(-9.9%) |
| Jun 2023 | - | $28.69 M(-6.9%) |
| Mar 2023 | - | $30.81 M(-7.6%) |
| Dec 2022 | $33.36 M(+103.6%) | $33.36 M(+424.9%) |
| Sep 2022 | - | $6.36 M(-28.2%) |
| Jun 2022 | - | $8.85 M(-23.4%) |
| Mar 2022 | - | $11.56 M(-29.5%) |
| Dec 2021 | $16.39 M(+62.4%) | $16.39 M(+134.6%) |
| Sep 2021 | - | $6.98 M(-26.6%) |
| Jun 2021 | - | $9.51 M(-27.0%) |
| Mar 2021 | - | $13.04 M(+29.2%) |
| Dec 2020 | $10.09 M | $10.09 M(-18.3%) |
| Sep 2020 | - | $12.35 M(-13.6%) |
| Jun 2020 | - | $14.30 M(+45.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $9.80 M(-29.5%) |
| Dec 2019 | $13.91 M(+388.9%) | $13.91 M(+649.8%) |
| Sep 2019 | - | $1.85 M(-49.1%) |
| Jun 2019 | - | $3.64 M(-33.9%) |
| Mar 2019 | - | $5.51 M(+93.7%) |
| Dec 2018 | $2.85 M(-84.6%) | $2.85 M(-88.0%) |
| Sep 2018 | - | $23.81 M(-15.1%) |
| Jun 2018 | - | $28.04 M(-18.6%) |
| Mar 2018 | - | $34.46 M(+86.5%) |
| Dec 2017 | $18.47 M(-23.1%) | $18.47 M(-27.1%) |
| Sep 2017 | - | $25.34 M(+12.7%) |
| Jun 2017 | - | $22.49 M(-23.2%) |
| Mar 2017 | - | $29.28 M(+21.8%) |
| Dec 2016 | $24.03 M(+563.9%) | $24.03 M(-15.3%) |
| Sep 2016 | - | $28.37 M(+487.8%) |
| Jun 2016 | - | $4.83 M(+196.3%) |
| Mar 2016 | - | $1.63 M(-55.0%) |
| Dec 2015 | $3.62 M(+1042.0%) | $3.62 M |
| Dec 2014 | $317.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is NeuroBo Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of NRBO is $22.43 M
What is the all time high annual cash & cash equivalents for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual cash & cash equivalents is $33.36 M
What is NeuroBo Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, NRBO annual cash & cash equivalents has changed by -$10.93 M (-32.76%)
What is NeuroBo Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NRBO is $21.67 M
What is the all time high quarterly cash and cash equivalents for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly cash and cash equivalents is $34.46 M
What is NeuroBo Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, NRBO quarterly cash and cash equivalents has changed by -$766.00 K (-3.41%)